In 2015, researchers discovered that some species, like Conus geographus, make venoms that contain con-insulin, a toxin that ...

Pasireotide, a new panreceptor analog, might control clinical symptoms and hormone release in patients resistant to standard somatostatin analog therapy. mTOR and tyrosine kinase inhibitors may ...

Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent ...

ACTH: Adrenocorticotrophic hormone; b.i.d.: Twice daily ... Glucocorticoid receptor antagonists (mifepristone) and somatostatin receptor antagonists (pasireotide) represent exciting new developments.

Researchers Show How Gut Hormones Control Aging in Flies and How It Relates to Human Biology Oct. 17, 2024 — The discovery of a gut-to-brain regulation pathway in flies calls for additional ...

The rising prevalence of gastrointestinal disorders and increased awareness of rare diseases are driving the ...

Submission of New Drug Application for Paltusotine for the Treatment of AcromegalyCompleted Upsized Public Offering of $575M of Common Stock ...